Cristina Cruz Zambrano
Member of the Cancer profiling research line
Email: cristina.cruz@umedicina.cat
ORCID: 0000-0002-6474-7504
Scientific Profile: URECERCA
Cristina Cruz is a lecturer at the University of Vic – Central University of Catalonia (UVic-UCC). Her research focuses on cancer biomarkers of prognosis and treatment response.
She graduated in Biochemistry in 1996 (University of Barcelona) and earned the doctorate in Biochemistry in 2001. In 2006 she graduated in Medicine (University of Barcelona) and is a Medical Oncology specialist since 2011. From 2011 to 2018 she was a clinical and translational investigator at Vall d’Hebron Institute of Oncology (VHIO). She participated in a number of clinical trials in the field of early drug development (Phase I) and Phase II & III clinical trials investigating targeted therapies for hereditary breast and ovarian cancers. As a postdoctoral researcher from VHIO’s Experimental Therapeutics Group, she also developed translational projects to investigate the determinants of treatment response and resistance among BRCA1/2 germline mutation carriers, including the functional biomarker RAD51. In 2019, she joined the Faculty of Medicine at UVic-UCC, where she teaches Human Genetics, Histology, Medical Embryology and Physiology.
My last happenings:
Bringing Science Closer to the Classroom for a Second Consecutive Year during European Researchers’ Night 2026
As part of European Researchers' Night 2026, PhD candidate Clara Masó once again visited Els Castanyers School in Viladrau to bring science closer to young students. For the second consecutive year, pupils from 3rd, 4th and 5th grade took part in interactive workshops designed to introduce them to scientific research, health, hygiene, microorganisms and the scientific method through hands-on activities and discussion. During the first visit, Clara introduced pupils to several key scientific concepts, including the scientific method, the contributions of women in science, how wounds heal and why some wounds fail to heal, advanced wound therapies used in [...]
Comprehensive proteomic profiling of platelet-rich plasma from elderly individuals: insights for autologous therapeutic applications
Authors: Anna Buisán-Farré, Montserrat Serra-Mas, Elisabet Sarri, Verónica Salgado-Pacheco, Gianluca Arauz-Garofalo, Antonia Odena-Caballol, Marta Vilaseca, Marina Gay, Marta Ferrer-Solà, Clara Masó-Albareda, Marta Casals-Zorita, Marta Otero-Viñas Clinical Proteomics. 2026 DOI: 10.1186/s12014-026-09630-3 Funding: Instituto de Salud Carlos III (PI19/01379 and PI24/00211), the European Union, the PECT Osona Transformació Social project (001-P-000382), the INVESTIGO programme (2022 INV-1 00037), and a doctoral fellowship from the University of Vic-Central University of Catalonia. Proteomics analyses were performed at the IRB Barcelona Mass Spectrometry and Proteomics Core Facility (IU16-015983). Read more Abstract Background Autologous platelet-rich plasma (PRP) is commonly used to enhance tissue repair. [...]
TR2Lab was present at ETRS 2026 Annual Meeting
Dr.Elisabet Sarri and PhD candidate Natalia Palacio, members of TR2Lab, participated in the ETRS 2026 Annual Meeting, "Research, Repair, Regenerate", held in Rouen, France, from 2 to 4 September 2026. Organized by the European Tissue Repair Society (ETRS), the meeting is recognized as one of the leading international forums for researchers and clinicians working in tissue repair, wound healing and regenerative medicine. The conference brought together experts from across Europe and beyond to discuss emerging strategies for improving wound healing, with scientific sessions covering topics such as inflammation and tissue repair, biomaterials and bioengineering, wound microbiology and biofilms, stem cells, [...]
